Search

Renown Health is pleased to announce that Kate A. Ward, Pharm.D., BCPS, has been promoted to serve as Vice President, Oncology for Renown Regional Medical Center.    Dr. Ward has over fourteen years of service to the organization, most recently as Director of Clinical Pharmacy responsible for the oversight of all clinical pharmacy activities at Renown Regional Medical Center, Renown South Meadows Medical Center, and Renown Rehabilitation Hospital. Additionally, Dr. Ward is the Residency Director of the Post-Graduate Year 1 (PGY1) Pharmacy Practice Residency at Renown. Over the last decade at Renown, Dr. Ward has served as Pharmacy Clinical Manager, Pharmacy Clinical Coordinator and Clinical Pharmacist.   Dr. Ward will bring her pharmacy clinical service experience (including ICU, Outpatient Infusion, Pediatrics, Oncology and Emergency Services), Inpatient Care, Clinical Research, and Hospital Formulary Management, Electronic Medical Record Integration and Optimization to this important new role.   As a dyad partner with Max J. Coppes, MD, PhD, MBA, Director of the William N. Pennington Cancer Institute at Renown, she will bring her clinical, operational, regulatory, and administrative experience to lead the oncology division. Dr. Ward, Dr. Coppes and the dedicated team will advance Renown’s mission to expand care, prevention, screening, research, and education with the goal of establishing the first National Institutes of Health, NCI designated Cancer Center for our State.   “We are thrilled to welcome Dr. Ward as our new Vice President of Oncology. She brings a wealth of experience and a passion for advancing patient care. Dr. Ward will play a pivotal role in sharing the future our oncology division and furthering our commitment to providing exceptional care,” said Chris Nicholas, CEO of Renown Regional Medical Center.    As a licensed pharmacist, Dr. Ward holds a Doctor of Pharmacy degree from the University of Colorado, Health Sciences Center. The Pharm.D. is a professional degree like a Doctor of Medicine (MD) or Doctor of Dental Surgery (DDS). As a doctorate, it represents the increasing responsibility pharmacists have in healthcare systems and the high trust Americans have in pharmacists.    Dr. Ward completed her residency at Stanford Hospital and Clinics. She graduated from the University of Nevada, Reno with her bachelor’s degree in Nutritional Sciences. Dr. Ward is active in several professional associations and currently serves as a Pharmacy Board member for HealthTrust; Vice Chair of the American Society of Health System Pharmacists® Council on Therapeutics; and Vice Chair for the Silver State Scripts Board for the State of Nevada. Dr. Ward was the 2022 recipient of the Nevada Society of Health System Pharmacists (NVSHP) President’s Award. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit renown.org/careers.

Read More About Exceptional Talent Joins William N. Pennington Cancer Institute at Renown; Dr. Kate Ward Brings Expertise and Vision as Vice President of Oncology Division

Beginning April 29, Renown Pharmacy – Pringle Will Be Open 24/7 Weeks after the only 24/7 pharmacy in Reno-Sparks announced it is no longer open overnight, Renown steps up to fill the community’s need, offering peace of mind knowing that any time, day or night, people can fulfill their essential medication prescriptions at Renown Pharmacy. Renown Health is pleased to announce that beginning on Monday, April 29, Renown Pharmacy - Pringle will expand hours to serve as the only 24/7 pharmacy in the area to serve all customers. The Renown Pharmacy located inside Renown Regional Medical Center will fill a gap left in the community after Walgreens on N. Virginia Street in Reno announced that they will no longer operate on a 24-hour, seven day a week schedule. Renown’s “all-hours, around the clock” pharmacy access will allow patients post-discharge from any area hospital the ability to fill their pharmaceutical prescriptions at any time, along with granting all community members the opportunity to pick up their prescriptions when it is most convenient for them. “We are proud to be able to step up to provide round-the-clock access to essential medications and healthcare services for our growing community, said Brian Erling, MD, MBA, President & CEO for Renown Health. “We understand the importance of accessibility to medications and healthcare support, especially during times of urgent need. Our decision to operate our pharmacy 24 hours a day, 7 days a week, reflects our commitment to serving the needs of our community and ensuring individuals have convenient access to the care they need, day and night.” “We are grateful for the pharmacy service that Walgreens provided the Reno-Sparks area for many years. We are excited that Renown can now provide our community with access to 24/7 Rx care,” said Adam Porath, Pharm.D., BCACP, BCPS, FASHP, Renown Health Vice President of Pharmacy Services. “By offering continuous pharmacy services, we aim to provide peace of mind to our customers and community- knowing that they can rely on us, any time, day, or night, to fulfill their prescription needs and offer professional guidance on medication management. Our talented team of pharmacists and techs are eager to serve our community with the Renown Pharmacy at Renown Regional Medical Center, starting Monday, April 29.” “In times of illness, timely access to medications is crucial for effective treatment and swift recovery. Whether its managing chronic conditions or addressing acute symptoms, adhering to prescribed medication schedules can significantly impact one’s health outcomes,” said Bill Plauth, MD, MMM, CPE, Chief Medical Officer for Renown Health. We believe that by extending our pharmacy hours, we can better support the health and well-being of our community, ensuring they receive care they deserve when they need it most. We invite our people to take advantage of our expanded pharmacy and experience the convenience and reliability of our 24/7 services.” Renown Pharmacy - Pringle is conveniently located on the first floor of Renown Regional Medical Center in Reno. The Renown Pharmacy is near Starbucks and specializes in hard-to-find pharmaceuticals at lower costs, such as certain compound medications not typically stocked at other retail locations. Prescriptions can be transferred to any of Renown’s three retail pharmacy locations by calling the most convenient location and allowing expert pharmacy staff to complete the process. You can then request refills and check your prescription status in the MyChart app. Renown Pharmacy Pringle, 75 Pringle Way: 775-982-7737 Renown Pharmacy South Meadows, 10101 Double R Blvd.: 775-982-5366 Renown Pharmacy Locust, 21 Locust St.: 775-982-5280 For full pharmacy information, visit: renown.org/pharmacy/. Renown Health continues to expand and hire in-demand clinical positions, including positions at Renown Pharmacy. Visit renown.org/careers to learn more.     About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®.

Read More About Filling The Community’s Need for a 24/7 Pharmacy

Only hospital in northern Nevada to receive national recognition for patient safety and quality Renown South Meadows Medical Center in south Reno has earned an “A” Hospital Safety Grade from The Leapfrog Group, a nonprofit watchdog organization that serves as a voice for health care consumers and purchasers, using their collective influence to foster positive change in U.S. health care. Leapfrog is the nation’s premier advocate of transparency in health care—collecting, analyzing, and disseminating data to inform value-based purchasing and improved decision-making. This national distinction recognizes Renown Health’s national accomplishments in ensuring safe, high-quality hospital care for patients. The Leapfrog Group is an independent, nonprofit organization that upholds the standard of patient safety in hospitals and ambulatory surgery centers. Developed under the guidance of a national expert panel, the Leapfrog Hospital Safety Grade uses publicly available hospital safety data to assign grades to more than 2,700 U.S. acute-care hospitals twice per year. Leapfrog assigns an “A,” “B,” “C,” “D” or “F” grade to general hospitals across the country based on over 30 measures of errors, accidents, injuries, and infections as well as the systems hospitals have in place to prevent them.  Leapfrog sets their standards using peer reviewed literature and expert opinion, peer comparisons, and alignment with existing national standards or performance targets. “We are very proud to recognize physicians, nurses, clinicians and the entire team at Renown South Meadows Medical Center for achieving exceptional Leapfrog performance in Patient-Centered Care, Critical Care, Nursing and Bedside Care for Patients, Patient Safety, Medication Safety, and Care for Total Joint Replacement and Elective Outpatient Surgery Patients,” said Brian Erling, MD, MBA, President and CEO, Renown Health. “As the only locally governed not-for-profit academic healthcare network in the region, Renown’s success is shared with our patients and community. We celebrate and thank our physicians, nurses, and caregivers for their continued dedication to making a genuine difference in the health and well-being of the people and communities we serve.” “Everyone who works at Renown South Meadows Medical Center should be proud of this ‘A’ Hospital Safety Grade,” said Leah Binder, president, and CEO of The Leapfrog Group. “It takes complete dedication at every level, and an ironclad commitment to putting patients first. I thank Renown South Meadows Medical Center’s leadership, clinicians, staff, and volunteers for caring so deeply for patients and their safety.” “We are proud of our affiliated physicians and teams who give their best every day, to ensure that every patient’s care and safety is their top priority,” said Sam Weller, MHPA, CEO, Renown South Meadows Medical Center. “We recognize that when you choose a hospital, you could be making a life-or-death decision. Not every hospital is the same. Performance on things like infection rates, surgical errors, or patient injuries varies considerably—and matters greatly. It’s important for consumers to know and consider these things when choosing what physicians, hospital, or Emergency Room to select for their care. We are very excited to be recognized as the only hospital to achieve this designation in northern Nevada, and only one of two in the state (the other being in Las Vegas).”   To see Renown South Meadows Medical Center’s full grade details and to access patient tips for staying safe in the hospital, visit HospitalSafetyGrade.org and follow The Leapfrog Group on Facebook, LinkedIn, Instagram and X (formerly Twitter) and via The Leapfrog Group newsletter.   The Hospital Safety Grade’s methodology is peer-reviewed and fully transparent, and the results are free to the public. Renown Regional Medical Center received a B score for Fall & Spring 2023. For more information on the Leapfrog Group and the Spring 2023 scores, please visit: hospitalsafetyscore.org. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated health care network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,400 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. For more information, visit renown.org.  About The Leapfrog Group Founded in 2000 by large employers and other purchasers, The Leapfrog Group is a national nonprofit organization driving a movement for giant leaps for patient safety. The flagship Leapfrog Hospital Survey and Leapfrog Ambulatory Surgery Center (ASC) Survey collect and transparently report hospital and ASC performance, empowering purchasers to find the highest-value care and giving consumers the lifesaving information they need to make informed decisions. The Leapfrog Hospital Safety Grade, Leapfrog's other main initiative, assigns letter grades to hospitals based on their record of patient safety, helping consumers protect themselves and their families from errors, injuries, accidents and infections. For more, follow us on Twitter, Facebook, LinkedIn and Instagram and sign up for our newsletter.

Read More About Renown South Meadows Medical Center Earns Highest "A" Hospital Safety Grade from The Leapfrog Group

Gilead Sciences, Inc. (Nasdaq: GILD) and the Renown Institute for Health Innovation (IHI) today announced a strategic collaboration to collect and analyze genetic and electronic health data that can enhance the understanding of nonalcoholic steatohepatitis (NASH) and potentially inform development of treatment options for the disease. Under the terms of the collaboration and license agreement, Gilead will provide funding to Renown IHI to sequence and analyze the DNA of 15,000 individuals living with NASH or nonalcoholic fatty liver disease (NAFLD) as well as a control cohort of 40,000 individuals in Nevada. “Combining the sequencing of protein coding DNA, with extensive electronic health record data will enable a deep analysis of the roles of genetics and environment in NASH incidence and progression,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “The analysis of these large datasets in collaboration with Renown IHI could help identify genetic variants that impact the risk of developing NASH and thereby advance the discovery and development of new treatments for this disease.” Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has 40,000 participants. “Combining genetic sequencing with large sets of data can play a critical role in understanding and identifying serious health risks, including diseases like NASH. We are excited to collaborate with Gilead to better understand the condition and its complexities,” said Anthony Slonim, MD., DrPH. “Any genetic variants identified in participants through the collaboration may be shared with the participants for patient care purposes.”     About NASH Nonalcoholic steatohepatitis (NASH) is a chronic form of liver disease characterized by excess fat in the liver, inflammation, and liver cell damage. Inflammation and liver cell damage can cause scarring of the liver, or fibrosis, and ultimately lead to cirrhosis or liver cancer. NASH is more common in people with certain conditions, including obesity and type 2 diabetes. There are currently limited approved treatments for patients living with NASH.   About Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.   About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown Health’s commitment has extended beyond traditional health care to include community health and well-being. Renown Health works to improve health care through science, research and genetics; forge community partnerships that improve lives and develop innovative models that are improving health care in Nevada. For more information, visit renown.org.    About Helix Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Powered by their proprietary Exome+™ assay—a panel-grade exome enhanced by more than 300,000 informative non-coding regions—Helix offers health systems a scalable solution which enables the discovery of medically relevant, potentially life-saving, genetic information. Additionally, Helix offers a suite of DNA-powered products for continued individual engagement and discovery. Helix is headquartered in the San Francisco Bay Area and has one of the world’s largest CLIA-certified, CAP-accredited Next Generation Sequencing labs, located in San Diego, California. Learn more at www.helix.com. Helix, the Helix logo, and Exome+ are trademarks of Helix Opco, LLC.   Gilead Forward-Looking Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this collaboration, and Gilead may fail to discover, develop and commercialize any product candidates for the treatment of NASH. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, as filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.   Additional Media Contact: Sung Lee, Investors                                                                                                                                                        650-524-7792 Arran Attridge, Media                                                                                                                                                        650-425-8975

Read More About Gilead Sciences and Renown Institute for Health Innovation Announce Strategic Collaboration to Advance Understanding of Nonalcoholic Steatohepatitis (NASH)

Always listening to the voice of the patient, Renown Health is pleased to welcome any two patient supporters to visit their loved ones during their Renown medical visit, surgery, birthing or hospital stay. Renown continues to have extra safety measures in place to protect the health of patients, visitors and healthcare employees, and as the situation changes with COVID-19, these guidelines are subject to change. Under this updated visitor policy, patients no longer need to identify their supporters ahead of their arrival. Patients may receive more than two visitors per day; however, to help ensure adequate physical distancing, only two guests are asked to visit at a time. All people entering Renown sites must continue bringing and wearing a face mask for their entire visit, including inside patient rooms. Renown’s visitor policy updates were inspired by family members, who requested that the policy be expanded to encourage two family members per day to be able to visit a loved one who was hospitalized at Renown. The request was approved by Dr. Debra Adornetto-Garcia, Chief Nursing Officer and Dr. Paul Sierzenski, Chief Medical Officer, both of Acute Services. With a high percentage of Renown hospital staff now vaccinated against COVID-19, declining hospitalizations of patients with COVID-19, and understanding that the best communication is in-person, as of April 28, 2021, Renown hospitals and medical practices now allow two visitors, instead of one, for all patients and have put extra safety measures in place to protect patients, visitors and healthcare employees. “We are pleased to expand our visitor policy and welcome two healthy adult patient supporters to accompany every patient to their Renown medical visit or hospital stay,” said Tony Slonim, MD, DrPH, President & CEO of Renown. “We are always looking to our patients’ lived experiences to help us address the health needs of our community. Just a few months ago, we were reminded by Darlene Randolph that the best care is ‘person-centered care’, which inspired us to be one of the first healthcare organizations in the nation to expand our visitor policy to all patients, including those with COVID-19. Today, we thank our patients’ family members for voicing the importance of a larger, connected support system to help foster the best healing environment for all patients.” “At Renown, the definition of ‘family’ is defined by the patient,” said Debra Adornetto-Garcia, DNP, RN, NEA-BC, AOCN, Chief Nursing Officer, Acute Services. “Our patients may have anyone they choose as their patient supporters, and these individuals serve as an invaluable extension of our care teams. Patient supporters are asked to partner with the patient’s healthcare team to assist in communicating to other family members and friends, participating in training and education activities and assisting the patient with complying with care and medication instructions.” “Visiting the hospital can be an anxious experience,” said Paul Sierzenski, MD, MSHQS, CPE, FACEP, Chief Medical Officer, Acute Services. “It’s incredible how the company of loved ones can reduce anxiety and promote healing. What we can do together with families to support patient care and excellent outcomes is greater than what any of us can do alone. We are glad to welcome patient supporters to our hospitals to help our patients feel more at ease, so they can focus on their recovery, health and healing.” Two patient supporters per patient are now able to access Renown campuses as noted: Renown Regional Medical Center and Renown South Meadows Medical Center: 8 a.m. to 8 p.m. For Intensive Care Units (ICU): 9 a.m. to 8 p.m. Visitors must be at least 12 years of age or older. Renown Children’s Hospital: Open access. For the Pediatric unit and Pediatric Intensive Care Unit (PICU): Visitors must be at least 12 years of age or older. For the Neonatal Intensive Care Unit (NICU): Visitors must be at least 18 years of age or older. Renown Rehabilitation Hospital: 8 a.m. to 5 p.m. One designated patient supporter is allowed to visit the patient inside their room throughout the duration of their stay. Other loved ones may visit from an exterior window, outside the patient's room. Our care team is also pleased to facilitate bedside virtual visits. In addition to in-person visits, there are many ways to brighten the day of a patient at Renown Hospitals. You can send a personalized message that will be hand-delivered to your loved one, call 775-982-4100 to speak with a patient, or our care team is pleased to facilitate virtual visits via computer or tablet from the bedside. Renown Health reserves the right to limit visitors in the best interests of patients, families, visitors or staff.   About Renown Health Renown Health is Nevada’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 6,500 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®.

Read More About Renown Health Further Expands Visitor Policy to Two Loved Ones

Together, will test over 30,000 qualifying study participants by 2023 for risk of cirrhosis and liver-related illnesses. Renown Institute for Health Innovation (IHI) announced today that the organization and Gilead Sciences, Inc. will be joining forces with Siemens Healthineers to offer the Enhanced Liver Fibrosis (ELF™) Test to people with risks for nonalcoholic steatohepatitis (NASH) enrolled in the Healthy Nevada Project (HNP). The ELF Test will help identify people most at risk for progressing to cirrhosis and liver-related outcomes and allow healthcare providers to intervene before irreparable damage occurs. This noninvasive blood test uses three serum biomarkers to create an ELF score from a predefined algorithm, which can be used by doctors to help evaluate if a patient requires increased medical care and monitoring for their condition. Nonalcoholic fatty liver disease (NAFLD), which includes NASH, is prevalent in Nevada and under-diagnosed, likely affecting more than 500,000 adult Nevadans. If undetected and untreated, NASH can result in liver cirrhosis and may require liver transplantation or lead to death. There are more than 12,000 people on a waitlist for liver transplantation in the U.S. and this number continues to rise due to the increasing prevalence of NAFLD. “Thanks to important data collected through our Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study, we now know that NASH is prevalent in the state of Nevada,” said Tony Slonim, M.D., DrPH, FACHE, president and CEO of Renown Health. “We are proud to expand our partnership with Gilead and begin working with Siemens Healthineers to improve health of those with liver disease and to take early detection one step further by offering Enhanced Liver Fibrosis, ELF testing for patients of Renown Health. This test provides our team of highly-skilled physicians an advanced, noninvasive method to actively assess dynamic liver fibrosis in study participants and intervene whenever necessary, contributing to a healthier Nevada.”  “Gilead believes that noninvasive tests, including the ELF Test, will help improve the experience of people living with NASH. These tests may help to diagnose liver disease, monitor disease progression and evaluate responses to treatment without the requirement for liver biopsy,” said Rob Myers, MD, Vice President, Liver Fibrosis Clinical Research at Gilead Sciences. “The ELF Test has proven itself to be a valuable tool in NASH management and we hope this partnership will further support its use in routine care.”  “We are very pleased that NASH patients in the Healthy Nevada Project now have access to the ELF Test which offers clinically useful prognostic information for their condition with the convenience of a simple blood test. Using our advanced laboratory expertise together with Renown IHI and Gilead, we can work towards better understanding of NASH and liver disease in a representative patient population,” said Sebastian Kronmueller, Head of Molecular Diagnostics at Siemens Healthineers. “We launched the Healthy Nevada Project to help people understand more about their health, to identify serious health risks, and to give people access to innovations like the ELF Test, so they can live their best lives,” said Renown’s chief scientific officer, Dr. Joseph Grzymski, who is also a research professor at the Desert Research Institute and principal investigator of the Healthy Nevada Project. It’s incredibly rewarding to be able to report clinical findings to help our 50,000 volunteer study participants, and to assist healthcare providers in helping their patients.” The provision of the ELF Test builds on a previously announced strategic collaboration between the Renown IHI and Gilead in July 2019. This ongoing partnership aims to collect and analyze de-identified genetic and electronic health data from 60,000 qualifying study participants to enhance the understanding of NAFLD and NASH and to potentially inform development of treatment options for these diseases.  About NAFLD and NASH NAFLD is a build-up of fat in the liver of people who do not have a history of alcohol misuse. It is normal for the liver to contain some fat, but if more than 5 percent of the liver content is fat, it’s considered a fatty liver (steatosis). NASH is the most severe form of NAFLD in which a person has liver cell damage and inflammation of the liver. Inflammation and liver cell damage can cause fibrosis, or scarring of the liver, and can cause decreased liver function (1). The symptoms of NASH are often silent or non-specific, making it difficult to diagnose. About one-third of people with NASH develop cirrhosis or irreversible liver damage (2). About the ELF™ Test The ELF Test is a noninvasive blood test that can quickly identify which patients are at an elevated risk for developing cirrhosis and other liver-related clinical events (LREs). In contrast to standard liver enzyme tests that reflect liver damage that has already occurred, the ELF Test combines three serum direct biomarkers of active fibrosis. The ELF Test algorithm measures each of these biomarkers to create an ELF score, which can be used as an aid to assess the risk for future disease progression. Doctors may use this ELF score to help evaluate if a patient requires increased medical care and monitoring for their condition. Individuals interested in determining their risk for NASH and its progression are encouraged to enroll in the Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study. Those who have already consented and participated in the study will be contacted with more information on how to receive an ELF blood test. For more information or to enroll, please contact RenownIHI@renown.org or (775) 982-6914. The Enhanced Liver Fibrosis (ELF™) Test kit is not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.  In the U.S., the ELF Testing Service is available from Siemens Healthcare Laboratory, LLC (SHL), a CLIA-certified laboratory located in Berkeley, Calif. The ELF Testing Service, including the establishment of performance characteristics, was developed by SHL. The ELF Test has not been cleared or approved by the U.S. Food and Drug Administration. SHL is regulated under CLIA as qualified to perform high complexity testing. The ELF Test is used for clinical purposes and should not be regarded as investigational use only or research use only. About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Health, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information visit, renown.org. About the Renown Institute for Health Innovation Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org. Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has over 60,000 participants. For more information, visit healthynv.org.  About Siemens Healthineers Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion. Further information is available at www.siemens-healthineers.com.Media Contact for Siemens Healthineers: Lance LongwellM: 610-448-6341E: lance.longwell@siemens-healthineers.com

Read More About Renown Institute Expands Partnership to Offer ELF Testing

Renown's Medications to Go program offers time-savings and convenience for patients and their families. It can be difficult leaving the hospital after a stay. Learning and understanding detailed care instructions and settling in to a new routine, can be an overwhelming experience for both patients and their caregivers. Plus, there’s the added inconvenience of visiting the pharmacy to pick up prescribed medications.  Because it is so inconvenient, one-third of these prescriptions never reach the patient, and remain in a basket at the pharmacy, awaiting pick-up. Because the patient never takes their medication, recovery time can take longer, and in some cases, the patient goes without the needed medications and may be readmitted to the hospital.   To make the process more convenient for patients and their families, Renown Pharmacy now offers a new Medications to Go program.  Patients can now receive Medications to Go at Renown hospitals. Opting in when they arrive, and the day they leave, their medication will be hand-delivered to them in their room by a member of Renown’s pharmacy team, along with medication counseling by a Renown pharmacist. There is no additional cost for patients to use this service aside from their normal medication copays. “Medications to Go is another example of how we are using new approaches to deliver an excellent patient and customer experience, and helping people choose, access, experience and prefer Renown Health providers and hospitals,” said Tony Slonim, MD, DrPH, president and CEO of Renown. “We want to help our patients on their journey to health and wellness.”  The Renown Pharmacy team has been recognized for several national best practice programs. A similar pilot program showed a 25 percent reduction in hospital readmission rates for patients with Medicaid insurance, emphasizing the need for the service for all patients at all Renown hospital locations. Since June 1, 2020, Medications to Go has been available to every patient at Renown Regional Medical Center, Renown South Meadows Medical Center and Renown Rehabilitation Hospital. “We’ve filled more than 1,600 prescriptions through the program to date,” said Adam Porath, Doctor of Pharmacy, and Renown’s interim director. “Patients are very happy – especially new moms and parents of our youngest patients at Renown Children’s Hospital.”      About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

Read More About Renown Pharmacy Introduces New Program: Medications to Go

Embraces patient and family-centered care, enhanced safety measures and new visiting hours.   Today, Renown Health announced the Patient Supporter program, recognizing the important role that family and friends play in the healing, recovery and care of patients and serve as integral members of the health care team. With a continued decline in COVID-19 patients and the move to Phase 2 of Governor Sisolak’s Silver State Stabilization program, and in alignment with the Nevada Hospital Association, Renown hospitals and medical practices are now allowing limited visitors for non-COVID-19 patients and have put extra safety measures in place to protect patients, visitors and healthcare employees. One healthy adult Patient Supporter may now accompany a patient to their Renown medical visit or hospital stay. Tony Slonim, MD, DrPH, President & CEO of Renown said, “We live by our values of caring, integrity, collaboration and excellence. We believe in ‘person-centered care,’ an approach that embraces the perspective of the patient and their loved ones, while promoting a healthy, encouraging environment for caregivers and addressing the health needs of our community.” At Renown, "family" is defined by the patient. The patient may designate anyone they choose as their Patient Supporter. The Patient Supporter may be asked to assist the health care team with communications to other family members and friends, participate in training and education activities and assist the patient with complying with care and medication instructions. Jen Richards, PhD, RN, Chief Nursing Officer for Acute Services explained, “The partnership between patients, families and healthcare providers is based on the understanding that everyone's role is important. What we do together is greater than what any of us can do alone. Involving families in the patient's care supports the healing process and can improve the outcome. This belief shapes our work, our services and the care we provide.” Beginning today, each patient may be accompanied by one healthy adult Patient Supporter. Enhanced safety measures in place include across all Renown sites to safeguard health include: • Wearing a mask at all times; • Observing hand hygiene practices; • Conducting health screenings upon each entry; • Implementing strict social distancing protocols; • Extra cleaning and disinfection of high-touch, public surface areas. In alignment with the state-wide guidelines, visitors will be limited to one Patient Supporter per patient and be able to access hospitals as noted: • Renown Children’s Hospital: Open access. (Two parents and/or guardians may be designated as Patient Supporters, however, due to current space      constraints, we ask that you visit one at a time). • Renown Regional Medical Center and Renown South Meadows Medical Center, 3 pm-8 pm • Renown Rehabilitation Hospital, 9 am-4 pm partnerships; the importance of including trusted support people in your care; Nutrition; the nurturing aspect of food; https://www.renown.org/find/renown-regional-medical- center/shops-at-renown/ Spirituality; wellness resources and the Spiritual Center & Estelle J. Kelsey Interfaith Sanctuary https://www.renown.org/explore/spiritual-care/interfaith-spiritual-center/ Healing arts, including art, music, Fianna’s Healing Garden and The John & Sue Dermody Children’s Healing Garden, serene environment designed to promote patient healing and environments conducive to health Physical, emotional safety, security and patient confidentiality. There are multiple ways to support patients at Renown Regional Medical Center, South Meadows Medical Center, Renown Children’s Hospital or Renown Rehabilitation Hospital. You can send a personalized message to a loved one and it will be hand-delivered to patients staying overnight. https://www.uat.renown.org/interact/contact-a-patient/. Staff are pleased to arrange video calls with loved ones. To speak with a patient, call 775-982-4100. Renown Care Providers Are Fighting the Good Fight For You. You may send a Thank You note or make a donation to support their efforts at https://www.renown.org/donations-covid-19/. For more detailed information on the Patient Supporter program visit https://www.renown.org/interact/ Please see b-roll to accompany this story here.     About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. For more information, visit renown.org.

Read More About Renown Patients Encouraged to Have One Supporter Accompany Them to Medical Visit or Hospital Stay

Renown Health announced today that it is now using ARxIUM’s Robotic IV Automation (RIVA) system in its pharmacy to streamline the production process of IV admixtures. RIVA is a fully automated compounding system designed to precisely and accurately prepare IV syringes and bags in hospital pharmacies. This state-of-the-art system is considered the gold standard when it comes to safety, effectiveness and precision in pharmacy technology. To operate the robot, pharmacists and pharmacy technicians load drugs into the machine, in addition to drug vials, syringes and IV bags. Everything that goes into RIVA receives a barcode as it’s loaded to help the robot identify each item. The operator then instructs the robot to create the drug and RIVA goes to work, allowing employees to go about other duties as the robot maximizes efficiency. RIVA validates each component during the admixture process including size, barcode and weight of each ingredient to ensure accuracy. For an added level of safety, RIVA uses high-intensity pulsed ultraviolet light for disinfection of all vial and bag parts prior to compounding the drugs. “The contamination of IV products usually comes from humans – from our skin, breath, hair or other particles in the air,” said Renown Regional Medical Center’s pharmacy manager, Derek Gillespie. “Plus, the repetitive process of a human mixing 100 items of the same thing and the possibility for distraction can lead to errors. By automating the complex admixture process using the RIVA system, we’re able to significantly reduce the risk of contamination and human error.”  RIVA has the continuous capability to learn how to produce new admixtures through detailed programming done by pharmacists and pharmacy technicians. The system stores the information so it can recreate the drug whenever it’s instructed to do so.  With the help of pharmacy staff, RIVA produces a batch of approximately 50 items at a time, and can make up to 500 admixtures a day. By using RIVA, the pharmacy’s goal is to have items available on hand to help meet patients’ needs quickly. Additionally, in the case of a drug shortage, RIVA would enable the pharmacy to make its own IV solutions or admix items unavailable for purchase.  Only 27 pharmacies in the country currently use the RIVA system. Up until recently, Renown’s pharmacy team did all of its admixtures manually. “It’s exciting to have this new technology in our pharmacy and to know that at Renown Health, we are leveraging the latest technology out there to make our patients as safe as possible,” said Tony Slonim, MD, DrPH, president and CEO of Renown. “Our staff takes pride in using technology like the RIVA system as it allows them to hone their craft on the best technology in the field. We look forward to maximizing our IV production capabilities and fulfilling our patient’s needs more efficiently than ever thanks to RIVA and the incredible team that operates the robot.” For b-roll of RIVA in action and an interview from Derek Gillespie, click here.     About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. For more information, visit renown.org About ARxIUM Based in Winnipeg, Manitoba and Buffalo Grove, Illinois, ARxIUM is an industry-leading developer of pharmacy automation, workflow and consulting solutions that improve safety, productivity and workflow. The company provides solutions to shared service centers and health system, hospital, long-term care, retail and government pharmacies. ARxIUM is the developer of the only fully automated IV compounding system in the market today, and offers automated packaging, dispensing, vial filling and high volume systems. In addition, the company provides inventory management, scheduling and workflow software, technical consulting, and system implementation assistance, among other services. ARxIUM is also the creator of the Pharmacy 4.0 approach, which seamlessly converges clinical pharmacy, central production and automation advancements into fully automated, interactive data processes. The approach allows pharmacies to better monitor and react in real-time to address patient care and medication delivery demands. For more information, visit www.arxium.com.

Read More About New Automated Robot System in Renown Health

Renown Health adds an electrostatic cleaning system to its list of innovative technology used to sanitize hospital rooms and equipment. During a time when many people might worry about seeking emergency care in fear of coming into contact with COVID-19, Renown Health is committed to the health and safety of everyone who enters our doors. As an added layer of protection for patients and staff, Renown is using a new electrostatic cleaning system to clean its emergency room. The same technology is also being used to sanitize Renown’s deployable medical facility outside its emergency room, employee dressing rooms and break areas, X-ray machines and more. The system kills 19 organisms in just two minutes including cold and flu viruses, MRSA and norovirus. “At Renown Health, we want our community to know that we are committed to providing a sanitary and safe environment,” said Renown’s manager of environmental services, Michael Yaranon. “Our electrostatic cleaning system is being used daily to help ensure our facilities are ready to safely care for our patients, as well as provide a clean environment for our caregivers who work in them. Since the beginning of this pandemic, we have continuously looked for new ways to expand our cleaning efforts, and the electrostatic cleaning system has served our facilities and hospital equipment well.”  In use at Renown since March of this year, the cleaning system uses a disinfecting solution included on the EPA’s list of registered antimicrobial products for use against novel coronavirus SARS-CoV-2, which is the cause of COVID-19. As an added safety precaution, the electrostatic technology helps the solution thoroughly clean and sanitize both hard and soft surfaces. This special cleaning technology is now being used in hospitals, commercial planes and hotels around the world to eliminate the spread of potentially dangerous pathogens. The handheld cleaning system is operated by a Renown employee. Once turned on, the machine uses an air compressor – with a force stronger than gravity – to dispel the disinfectant solution. Inside the device, an electrode introduces an attractive charge and atomizes the solution. Once the solution is propelled, the charged particles are instantly attracted to the surface being cleaned. The solution then reaches and wraps around the entire surface to uniformly coat and disinfect.  “Between our electrostatic cleaning system, germ-zapping robots, and diligent team of employees all operating around the clock to clean and disinfect, we truly are fighting the good fight against germs at Renown Health,” said Yaranon. “Please do not put off coming to Renown for emergency care if you need it – our facilities and equipment are extremely safe and ready to serve you.” For an in-person or virtual demo of Renown’s electrostatic cleaning system, please send an email to news@renown.org to coordinate a time.  For up-to-date information on Renown’s approach to keeping our community safe, visit our website at https://www.renown.org/covid-19/.   About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. For more information, visit renown.org.

Read More About Renown Using Technology to Help Keep Community From Superbugs

Adam D. Porath, Pharm.D., BCACP, BCPS-AQ Cardiology is promoted to serve future generations and improve the health and well-being of Nevadans. Renown Health is excited to announce Dr. Adam Porath has been promoted to vice president, pharmacy to lead clinical pharmacy and pharmacy operations and ensure excellent care for patients and families.  “We are pleased to promote an experienced and talented leader like Dr. Adam Porath,” said Dawn D Ahner, DSc, FACHE, Chief Operating Officer, Acute Services. “Adam will continue to foster a culture of caring and excellence, while ensuring the highest level of pharmacy practice and experience for both care providers and patients.”  Dr. Porath has served in roles within pharmacy at Renown since 2006. Since June 2020, he has served as Interim Director of Pharmacy where he has led strategic planning for pharmacy operations, precepted students and residents, identified business growth opportunities, developed novel clinical pharmacy services and oversaw quality assurance of pharmacy operations. He began his career as a pharmacy practice resident at Renown Regional Medical Center in Reno.  “I am honored to be given the opportunity to serve the medical community and patients of Renown Health,” said Dr. Porath. “What a source of pride it is to be able to deliver the high-quality, compassionate patient care Renown is known for, and to help serve and lead in the pharmacy profession.” Dr. Porath received his doctor of pharmacy degree from Idaho State University. He is a board certified pharmacotherapy specialist with added qualifications in cardiology and board certified ambulatory care pharmacist. Dr. Porath has a BS in Biology from the University of Nevada, Reno.  Dr. Porath serves as adjunct clinical faculty for several colleges of pharmacy including the University of New England, Oregon State University, University of New Mexico, Idaho State University and University of Wyoming. He has been published in several peer-reviewed journals including CHEST, Clinical Infectious Diseases, and the Canadian Medical Association Journal.  Here in Nevada, Dr. Porath successfully lobbied the Nevada Legislature on behalf of the Nevada Society of Health System Pharmacists (NVSHP) to pass Collaborative Drug Therapy Management (CDTM) legislation in 2011, permitting Nevada pharmacists to adjust drug therapy per physician-signed protocol in any practice setting, as long as the pharmacist is under a physician’s direct supervision. Currently, 48 states permit some degree of CDTM. In 2017, Adam helped to pass further expansion of the pharmacy practice act. He is currently serving as a director at large of the NVSHP board. Dr. Porath has served as a state of Nevada delegate to the American Society of Health System Pharmacists (ASHP) House of Delegates since 2012. In 2018, Dr. Porath was appointed to the Nevada Attorney General’s statewide partnership on the opioid crisis. In 2019, he was appointed to the ASHP Council on Public Policy.  In U.S. News and World Report Best Hospital rankings, Renown South Meadows Medical Center was listed #1 in the State of Nevada. Renown Regional Medical Center was named #2 Best Hospital in Nevada. A hospital's score is based on multiple data categories, including patient outcomes, safety and volumes. Hospitals earning a high performing rating were significantly better than the national average.  About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project® . For more information, visit renown.org.

Read More About Renown Health Welcomes New Vice President, Pharmacy

The Healthy NV Project® launches a new study to identify how private well water could impact the health of those living in the household. You use your faucet to wash your hands, make coffee and fill your water bottle. However, for approximately 41,000 people in Washoe and Churchill Counties who rely on private well water, there may be unseen contaminants present in their H2O, which could be affecting their health. The Healthy Nevada Project®, with support from the National Institutes of Health (NIH), is launching a new study to discover how private well water quality impacts the health of well owners. By providing free water testing kits to interested Healthy Nevada Project® participants, researchers will collect samples and give results back to well owners, along with resources for potential treatment options. Data from previous studies in Nevada show elevated concentrations of heavy metals in some private, household wells. Since water from household wells is not monitored for quality by government agencies, well water testing helps ensure water does not contain dangerous levels of heavy metals, such as lead, which can lead to adverse health impacts.  Those with a household well interested in receiving a free water testing kit must be enrolled in the Healthy Nevada Project’s population genetic screening study and consent to be a part of further research. People interested in joining the study can simply sign up to receive a genetic spit test kit in the mail or join the waitlist to be notified when in-person testing resumes. “The goals of the Healthy Nevada project are to improve population health and better understand processes that increase disease risks, such as cancer. In this study, we engage with our study participants and inform them about the impact of the environment on their health, while researching environmental contaminants that may elevate cancer risk,” said Joseph Grzymski, Ph.D., research professor at DRI, principal investigator of the Healthy Nevada Project® and chief scientific officer for Renown Health. “During a time where people are spending more time at home, we’re excited to launch this multi-disciplinary study that dives into possible health impacts of a household’s water source.”  “As the Healthy Nevada Project continues to serve over 54,000 research volunteers, we are proud to provide helpful information to participants, so they can make life-changing improvements to their home environment,” said Tony Slonim, M.D., DrPH, FACHE, president and CEO of Renown Health and co-director of the Healthy Nevada Project. “This allows every person with well water in Nevada, to have important information, at no charge, to help live healthier and better lives and to protect their family’s health.” The Healthy Nevada Project® is the fastest-enrolling genetic study in the country. The Project is also the first of its kind to return clinical results to study volunteers, which means participants can learn their genetic risks tied to heart disease and certain cancers, as well as lifestyle changes that could potentially help reduce their risk and prevent disease. To enroll in the Healthy Nevada Project, please visit healthynv.org.      Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org.

Read More About Could Private Well Water Unlock Health Insights?